Certified by Founder Lodge
Cambridge Innovation Capital
United Kingdom - Cambridge
INVESTOR
1 Disclosed Funding Rounds $11,500,000
8 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for
Company | Date | Round | Raised |
---|---|---|---|
Salience Labs | May, 12 ,2022 | Seed | $11,500,000 |
Seldon | March, 17 ,2023 | Series B | $20,000,000 |
Mosaic TX | April, 05 ,2023 | Series A | $28,000,000 |
Complement Therapeutics | April, 18 ,2023 | Series A | $78,929,000 |
Riverlane | April, 24 ,2023 | Series B | $18,685,000 |
T-Therapeutics Ltd | November, 16 ,2023 | Series A | $59,707,000 |
Secondmind | November, 29 ,2023 | Unknown | $16,000,000 |
Nuclera | October, 17 ,2024 | Unknown | $75,000,000 |